{"result": "(\"entity\"<|>JAPAN THYROID ASSOCIATION<|>ORGANIZATION<|>The Japan Thyroid Association is a professional organization that focuses on thyroid health and research, providing guidelines and conducting nationwide surveys related to thyroid conditions.)\n##\n(\"entity\"<|>JAPAN ENDOCRINE SOCIETY<|>ORGANIZATION<|>The Japan Endocrine Society is a professional organization dedicated to the study and treatment of endocrine disorders, including thyroid conditions, and collaborates on guidelines and research.)\n##\n(\"entity\"<|>THYROID STORM<|>EVENT<|>Thyroid storm is a severe and life-threatening condition resulting from untreated hyperthyroidism, characterized by an extreme increase in thyroid hormone levels and requiring immediate medical intervention.)\n##\n(\"entity\"<|>TIAMAZOL<|>ORGANIZATION<|>Tiamazol is a medication used to treat hyperthyroidism by inhibiting the production of thyroid hormones, often prescribed during pregnancy with caution due to its potential effects on lactation and fetal development.)\n##\n(\"entity\"<|>PROPYLTHIOURACIL<|>ORGANIZATION<|>Propylthiouracil (PTU) is a medication used to manage hyperthyroidism, particularly during the first trimester of pregnancy, as it is considered to have less severe teratogenic effects compared to tiamazol.)\n##\n(\"entity\"<|>HCG<|>ORGANIZATION<|>Human Chorionic Gonadotropin (HCG) is a hormone produced during pregnancy that stimulates the production of thyroid hormones and affects TSH levels in pregnant women.)\n##\n(\"entity\"<|>GUIDE ATA 2017<|>EVENT<|>The Guide ATA 2017 provides diagnostic and management recommendations for thyroid disease during pregnancy, including reference ranges for thyroid hormone levels.)\n##\n(\"entity\"<|>LACTATION<|>EVENT<|>Lactation is the process of feeding infants with breast milk, during which certain medications can affect the infant's thyroid function and development.)\n##\n(\"entity\"<|>PREGNANCY<|>EVENT<|>Pregnancy is a physiological condition that significantly alters thyroid hormone production and metabolism, necessitating careful management of thyroid disorders.)\n##\n(\"relationship\"<|>JAPAN THYROID ASSOCIATION<|>GUIDE ATA 2017<|>The Japan Thyroid Association published the Guide ATA 2017, which outlines recommendations for managing thyroid conditions during pregnancy<|>8)\n##\n(\"relationship\"<|>JAPAN ENDOCRINE SOCIETY<|>GUIDE ATA 2017<|>The Japan Endocrine Society collaborated with the Japan Thyroid Association on the Guide ATA 2017 for managing thyroid disease during pregnancy<|>8)\n##\n(\"relationship\"<|>THYROID STORM<|>JAPAN THYROID ASSOCIATION<|>The Japan Thyroid Association provides diagnostic criteria and clinical features for thyroid storm based on nationwide surveys<|>7)\n##\n(\"relationship\"<|>TIAMAZOL<|>LACTATION<|>Tiamazol is a medication that can be detected in breast milk, which raises concerns about its use during lactation<|>6)\n##\n(\"relationship\"<|>PROPYLTHIOURACIL<|>LACTATION<|>Propylthiouracil is also detected in breast milk but is considered relatively safer for use during lactation compared to tiamazol<|>6)\n##\n(\"relationship\"<|>HCG<|>PREGNANCY<|>HCG levels increase during pregnancy and influence thyroid hormone production and TSH levels<|>7)\n##\n(\"relationship\"<|>GUIDE ATA 2017<|>PREGNANCY<|>The Guide ATA 2017 provides specific recommendations for managing thyroid hormone levels during pregnancy<|>8)\n##\n(\"relationship\"<|>THYROID STORM<|>PREGNANCY<|>Thyroid storm can occur in pregnant women with untreated hyperthyroidism, necessitating careful monitoring and management<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ideas, con lo que disminuye los niveles de hormonas tiroideas de una forma aún más rápida que los antitiroideos. La dosis recomendada son 200 mg diarios de yoduro potásico. Por lo tanto, todas las opciones pueden ser útiles (opción D correcta).\n\nReferencias:\n- Akamizu T, Satoh, Isozaki O, Suzuk A, Wakino S, Iburi T, et al, for the Japan Thyroid Association. Diagnostic Criteria, Clinical Features, and Incidence of Thyroid Storm Based on Nationwide Surveys. Thyroid. 2012;22:661-79.\n- Carroll R, Matfin G. Endocrine and metabolic emergencies: thyroid storm. Ther Adv Endocrinol Metab. 2010;1:139-45.\n- Isozaki O, Satoh T, Wakino S, Suzuki A, Iburi T, Tsuboi K, et al. Treatment and management of thyroid storm: analysis of the nationwide surveys: The taskforce committee of the Japan Thyroid Association and Japan Endocrine Society for the establishment of diagnostic criteria and nationwide surveys for thyroid storm. Clin Endocrinol (Oxf). 2016;8:912-8.\n- Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, Tsuboi K, et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition). Endocr J. 2016;63:1025-64.\n\n## 19 ¿Cuál de los enunciados siguientes es cierto sobre el hipertiroidismo y el embarazo/lactancia?\n\nA. En la lactancia natural o materna no se puede dar tiamazol a la madre por el elevado riesgo de hipotiroidismo en el lactante.\nB. El hipertiroidismo subclínico durante el embarazo no suele necesitar tratamiento.\nC. Durante el embarazo es muy importante para la salud maternofetal mantener unos niveles normales de TSH (iguales a los de las mujeres adultas no embarazadas).\nD. En el primer trimestre del embarazo no se debe utilizar propiltiouracilo (PTU).\n\nCOMENTARIO\n\nTanto el tiamazol como el propiltiouracilo (PTU) se detectan en la leche de mujeres hipertiroideas tratadas con estos fármacos. Sin embargo, lo hacen en cantidades muy pequeñas. En efecto, se ha calculado que únicamente el 0,1-0,2% del tiamazol ingerido se excreta por la leche materna. Esto supone que de una dosis de 40 mg de tiamazol pasarían al lactante 70 µg. Tampoco se ha visto ninguna alteración ni en las pruebas de función tiroidea ni en el desarrollo neurocognitivo de lactantes cuyas madres tomaron tiamazol durante la lactancia. Así pues, su utilización en la lactancia es relativamente segura, aunque se aconseja no sobrepasar los 20 mg diarios de tiamazol (opción A falsa).\n\nEn cuanto a la segunda opción, es importante considerar que durante el primer trimestre del embarazo los niveles de TSH disminuyen en respuesta fisiológica a la estimulación del receptor de la TSH por la HCG, de forma que en un 5% de las gestantes, en la semana 11 de gestación, los niveles de TSH están por debajo de 0,1 mUI/l. En estos casos no es pre-\n---\nTIROIDES 3\n\nciso tratamiento, ya que habitualmente se recuperan hacia la 14-18 semana de gestación (opción B correcta).\n\nEl embarazo produce una serie de modificaciones sobre la fisiología normal del tiroides: la producción de hormonas tiroideas aumenta aproximadamente un 50%, la HCG placentaria estimula la producción de hormonas tiroideas, disminuye los niveles de TSH y aumenta el aclaramiento renal de yodo. Estos cambios hacen que se modifiquen los niveles de referencia tanto de la T4L como de la TSH. En la Guía ATA 2017 sobre diagnóstico y manejo de la enfermedad tiroidea durante la gestación se recomienda establecer rangos de referencia específicos poblacionales para cada trimestre de embarazo. Si no los hubiera, recomiendan fijar un límite superior de referencia para la TSH de 4,0 mUI/l, 0,5 mUI/l menor que los de la mujer no embarazada (opción C falsa).\n\nLos antitiroideos, tanto el PTU como el tiamazol han demostrado efectos teratogénicos, que llegan al 2-4% de los niños expuestos al tiamazol durante el embarazo temprano. Sin embargo, los efectos del PTU parecen ser menos graves que los del tiamazol, por lo que se recomienda su utilización preferente, en caso de que sea necesario su uso, durante el primer trimestre de gestación.\n\nAsí, la Guía ATA 2017 indica que hasta la semana 16 de gestación se recomienda el PTU como tratamiento del hipertiroidismo materno, y que si estuvieran en tratamiento con tiamazol, deberían ser tras\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}